Net income · 2018–2025

Ascendis Pharma net income

−$258M+$152M · FY2025

Ascendis Pharma (ASND) reported −$258M in net income for fiscal 2025, +$152M from the year before.

−$154M2018−$244M2019−$479M2020−$454M2021−$614M2022−$521M2023−$409M2024−$258M2025
Ascendis Pharma — Net income, 2018–2025
Fiscal yearNet incomeChangeFiling
FY20252025-12-31−$258M+$152MOpen →
FY20242024-12-31−$409M+$111MOpen →
FY20232023-12-31−$521M+$93.6MOpen →
FY20222022-12-31−$614M−$160MOpen →
FY20212021-12-31−$454M+$24.9MOpen →
FY20202020-12-31−$479M−$234MOpen →
FY20192019-12-31−$244M−$90.4MOpen →
FY20182018-12-31−$154M—Open →

Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Net income at companies of similar size

Full ranking by net income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ascendis Pharma net income |url=https://companiesranked.com/en/company/ascendis-pharma/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ascendis Pharma net income. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/net-income

BibTeX

@misc{companiesranked-en-company-ascendis-pharma-net-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ascendis Pharma net income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/net-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026

{{cite web |title=Ascendis Pharma net income — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ascendis Pharma overview